4/A//SEC Filing
Almenoff June Sherie 4/A
Accession 0001492647-25-000004
CIK 0000034956other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 6:16 PM ET
Size
7.6 KB
Accession
0001492647-25-000004
Insider Transaction Report
Form 4/AAmended
Almenoff June Sherie
Director
Transactions
- Purchase
Common Stock
2025-11-18$7.52/sh+1,900$14,280→ 1,993 total(indirect: By LLC) - Purchase
Common Stock
2025-11-17$7.15/sh+93$665→ 93 total(indirect: By LLC)
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F2]This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeother
Related Parties
1- filerCIK 0001492647
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 6:16 PM ET
- Size
- 7.6 KB